Equities

Spero Therapeutics Inc

Spero Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.36
  • Today's Change0.015 / 1.12%
  • Shares traded106.34k
  • 1 Year change+9.27%
  • Beta0.6256
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue1045418
OPERATING EXPENSES
Cost of revenue total------
Selling, general and admin. expenses, total263642
Depreciation/amortization------
Unusual expense(income)5.3115--
Other operating expenses, total------
Total operating expense8299106
Operating income21(46)(88)
Other, net(0.01)(0.06)(0.4)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes25(46)(90)
Provision for income taxes2.60----
Net income after taxes23(46)(90)
Minority interest------
Net income before extra. Items23(46)(90)
Total extraordinary items------
Net income23(46)(90)
Inc.avail. to common excl. extra. Items23(46)(90)
Inc.avail. to common incl. extra. Items23(46)(90)
EPS RECONCILIATION
Basic/primary weighted average shares533831
Basic/primary eps excl. extra items0.43(1.23)(2.91)
Basic/primary eps incl. extra items0.43(1.23)(2.91)
Dilution adjustment------
Diluted weighted average shares533831
Diluted eps excl. extra items0.43(1.23)(2.91)
Diluted eps incl. extra items0.43(1.23)(2.91)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental02.611.94
SUPPLEMENTAL INCOME
Depreciation, supplemental0.400.870.65
Total special items5.3115--
NORMALISED INCOME
Normalized income before taxes31(31)(90)
Effect of special items on income taxes0.540--
Income tax excluding impact of special items3.140--
Normalized income after tax28(31)(90)
Normalized income avail. to common28(31)(90)
Basic normalized EPS0.52(0.83)(2.91)
Diluted normalized EPS0.52(0.83)(2.91)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.